Christopher David Ozeroff - S.V.P., General Counsel at Oruka Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
S.V.P., General Counsel
Stock Symbol
ORKA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher David Ozeroff since 12/25/2023

Holdings reported by Christopher David Ozeroff for Oruka Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 51K $127K $2.50 Dec 14, 2021 Direct
Stock Option (right to buy) 27.5K Dec 14, 2021 Direct Common Stock

Transactions reported by Christopher David Ozeroff for Oruka Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.